Medtronic Q1 Beat, Guidance Raised, and Intl Sentire Expansion Announced
Sep 1, 2026, 9:56 AM EDT2 sourcesAI-analyzed
Why it may matterVerify against the original reporting
Solid earnings beat and higher guidance justify near-term stock appreciation; international partnership adds growth optionality and could lift multiple valuation as Sentire adoption expands.
AI summary
What happened, with direct paths to the underlying reporting
Medtronic delivered a stronger-than-expected first quarter, beating EPS and revenue forecasts and lifting FY27 adjusted EPS guidance. The company also disclosed a $700 million strategic partnership with Cornerstone Robotics to broaden Sentire Surgical System access in select non-U.S. markets. This earnings beat combined with international expansion may support near-term multiple expansion and longer-term growth.
MDT Q1 EPS $1.45 vs $1.39 est; revenue $9.756B vs $9.545B.
Raises FY27 adjusted EPS guidance.
Announces $700M Cornerstone Robotics partnership for Sentire globally (non-U.S.).
MDT shares up about 5% on the news.
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.
Related signals
More source-backed signals connected by company or event